GSK Shares Jump After Drugmaker Boosts Outlook, Positive …

3 days ago · American depositary shares of GSK jumped more than 8% Wednesday after the drugmaker reported better-than-expected quarterly results and boosted its long-term sales …

CouponFollow Extension

8%
OFF

GSK Shares Jump After Drugmaker Boosts Outlook, Positive …

2 weeks from now

3 days ago · American depositary shares of GSK jumped more than 8% Wednesday after the drugmaker reported better-than-expected quarterly results and boosted its long-term sales …

wsj.com

$2
OFF

GSK Stock Jumps On Long-Term Outlook Boost, $2.5B Share …

2 weeks from now

3 days ago · GSK Plc's U.S.-listed shares surged Wednesday after the pharmaceutical firm boosted its long-term outlook and launched a $2.5 billion stock buyback on the back of …

investopedia.com

6%
OFF

GSK Shares Jump 6% As Firm Raises Sales Target, Boosts Dividends

2 weeks from now

3 days ago · GSK shares surge as the drugmaker raises its 2031 sales target to over £40bn, boosts dividends, and announces a £2bn share buyback plan. Invezz Signals Join us for free …

invezz.com

6%
OFF

GSK Launches $2.5 Billion Buyback, Lifts Sales Target After Stellar ...

2 weeks from now

3 days ago · GSK's Q4 EPS and sales beat estimates Shares jump 6% R&D investment to focus on speciality medicines Feb 5 (Reuters) - GSK (GSK.L), opens new tab launched a 2 billion …

reuters.com

$2
OFF

GSK Lifts Long-Term Outlook On Drug Pipeline, Buys Back Shares

2 weeks from now

3 days ago · (Bloomberg) -- GSK Plc plans to buy back £2 billion ($2.5 billion) of shares as it raised its long-term growth outlook on optimism around the drug pipeline. The British …

yahoo.com

6%
OFF

GSK Shares Surge Around 6% As Drugmaker Raises Sales Target And …

2 weeks from now

3 days ago · Invezz.com - Shares of British pharmaceutical giant GSK (LON: GSK) surged on Wednesday after the company raised its long-term sales forecast and reported strong financial …

investing.com

6%
OFF

GSK Stock Higher On Revised Long-term Guidance (GSK:NYSE)

2 weeks from now

3 days ago · GSK shares added ~6% in London trading on Wednesday after the British drugmaker lifted its 2031 outlook and announced a new share buyback program alongside …

seekingalpha.com

$2
OFF

GSK Issues $2.5 Billion Buyback, Raises Midterm Outlook After …

2 weeks from now

3 days ago · By Helena Smolak . GSK plans to buy back $2.50 billion in shares and raised its midterm sales target, citing promising pipeline developments. The British pharmaceutical giant …

morningstar.com

9%
OFF

GSK Boosts Outlook Backed By Solid Drug Pipeline

2 weeks from now

Jan 31, 2024 · Details of GSK’s Results and 2024 Outlook In Q4 FY23, GSK’s sales increased 9% year-over-year to £8.05 billion, and adjusted earnings per share (EPS) grew 12% to 28.9p. …

businessinsider.com

7%
OFF

GSK Surges 7% After Bumping Its 2031 Outlook To North Of $50

2 weeks from now

3 days ago · (Bloomberg) -- GSK Plc plans to buy back £2 billion ($2.5 billion) of shares as it raised its long-term growth outlook on optimism around the drug pipeline.Most Read from …

yahoo.com

$3
OFF

GSK Plans £2 Billion Share Buyback, Boosts Long-term Outlook

2 weeks from now

3 days ago · GSK plans to buy back £2 billion (S$3.4 billion) of shares as it raised its long-term growth outlook on optimism around its drug pipeline. The British drugmaker boosted its 2031 …

businesstimes.com.sg

$50
OFF

GSK Surges After Bumping Its 2031 Outlook To North Of $50 Billion

2 weeks from now

2 days ago · Specifically, GSK called for more than 40 billion pounds in 2031 sales, up from its previous outlook for north of 38 billion pounds. That translates to $50.07 billion, up from …

investors.com

5%
OFF

GSK Shares Jump On $2.2 Billion Zantac Settlement - Yahoo Finance

2 weeks from now

Oct 10, 2024 · (Reuters) -GSK shares jumped as much as 6.5% on Thursday after the British drugmaker struck a $2.2 billion settlement over U.S. lawsuits that alleged its discontinued …

yahoo.com

8%
OFF

Stock Market News, Feb. 5, 2025: S&P 500 Turns Higher; Google, …

2 weeks from now

3 days ago · GSK Shares Jump After Drugmaker Boosts Outlook, Positive Quarterly Results ... American depositary shares of GSK jumped more than 8% Wednesday after the drugmaker …

wsj.com

8%
OFF

GSK Surges 8% After Bumping Its 2031 Outlook To North Of $50

2 weeks from now

2 days ago · We recently compiled a list of the 10 Companies Jump on Better Earnings, Outlook. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the …

yahoo.com

6%
OFF

GSK Shares Surge Around 6% As Drugmaker Raises Sales Target And …

2 weeks from now

3 days ago · Shares of British pharmaceutical giant GSK surged on Wednesday after the company raised its long-term sales forecast and reported strong financial results for 2024. The …

tradingview.com

54%
OFF

GSK's Buyback, Upgraded Guidance Boost FTSE 100

2 weeks from now

3 days ago · The UK's FTSE 100 ended Wednesday's trading session 0.54% higher, led by GSK GSK after the pharmaceutical giant raised its long-term growth outlook and announced a new …

tradingview.com

$2
OFF

GSK Plans £2 Billion Share Buyback, Boosts Long-Term Outlook

2 weeks from now

(Bloomberg) -- GSK Plc plans to buy back £2 billion ($2.5 billion) of shares as it raised its long-term growth outlook on optimism around the drug pipeline. The British drugmaker boosted its …

msn.com

2%
OFF

Britain's GSK Lifts Outlook After Drug Sales Help It Beat Forecasts

2 weeks from now

Oct 27, 2021 · The drugmaker now expects 2021 adjusted earnings per share to fall by between 2% and 4% at constant exchange rates, excluding any boost from its COVID-19 offerings. It …

reuters.com

7%
OFF

GSK (GSK) Stock Price, News & Analysis - MarketBeat

2 weeks from now

Jan 29, 2025 · Since then, GSK shares have increased by 3.7% and is now trading at $35.0620. View the best growth stocks for 2025 here. How were GSK's earnings last quarter? GSK plc …

marketbeat.com

FAQs about GSK Shares Jump After Drugmaker Boosts Outlook, Positive … Coupon?

Why did GSK shares surge around 6%?

The post GSK shares surge around 6% as drugmaker raises sales target and boosts dividends appeared first on Invezz Shares of British pharmaceutical giant GSK surged on Wednesday after the company raised its long-term sales forecast and reported strong financial results for 2024. ...

Why did GSK boost its 2031 sales forecast?

The British drugmaker boosted its 2031 sales forecast to over £40 billion, up from the more than £38 billion it previously expected. GSK said this reflected progress in its late stage pipeline, including several oncology medicines. ...

Does GSK invest in R&D?

GSK will increase and prioritize R&D investment in its respiratory, immunology and inflammation, oncology and HIV drugs, Chief Executive Officer Emma Walmsley said in a statement Wednesday. Overall, spending on R&D is expected to increase in line with sales, the company said. ...

Does GSK need more pipeline wins?

“GSK needs more pipeline wins to narrow the gap between its 2031 sales target of £40 billion and consensus’ £34 billion,” Bloomberg Intelligence’s senior industry analyst John Murphy said in a note. The company is hoping its bet on cancer drugs will pay off, agreeing in January to buy cancer biotech IDRx Inc. for as much as $1.15 billion. ...

Does GSK pay a dividend?

GSK has declared a dividend for fourth quarter of 16 pence per share and 61 pence per share for full year 2024. The expected dividend for 2025 is 64 pence per share. For the fourth quarter, profit before tax grew to 563 million pounds from last year's 379 million pounds. ...

How did GSK perform on the FTSE 100?

The stock climbed 5.9% in early trading, making it the top performer on the FTSE 100 and on track for its biggest one-day gain since 2022. GSK increased its 2031 sales target to more than £40 billion, up from its previous estimate of £38 billion. ...